Levothyroxine Tied to Increased Osteoporosis Risk in Seniors
A study presented at the Radiological Society of North America meeting suggests that levothyroxine, a common medication for hypothyroidism, may be linked to bone density loss in older adults, even when thyroid hormone levels are within the normal range. The research, using data from the Baltimore Longitudinal Study of Aging, found that levothyroxine users experienced greater bone mass loss over a median follow-up of 6.3 years compared to non-users. The study highlights the need for regular monitoring and risk-benefit assessments for older adults on levothyroxine.
